In addition, carriers of rare heterozygous loss-of-function mutations in APOA5 that increased plasma TG levels had a twofold increased risk of early CHD [45], but these variants were also associated with increased LDL-C and decreased HDL-C. This evidence concerns the gene APOA5 and coronary artery disorder.